<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28">
 <label>28.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yanguez</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Hunziker</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Dobay</surname>
    <given-names>MP</given-names>
   </name>
   <name>
    <surname>Yildiz</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Schading</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Elshina</surname>
    <given-names>E</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target</article-title>. 
  <source>Nat Commun</source>. (
  <year>2018</year>) 
  <volume>9</volume>:
  <fpage>3679</fpage>. 
  <pub-id pub-id-type="doi">10.1038/s41467-018-06119-y</pub-id>
  <?supplied-pmid 30206219?>
  <pub-id pub-id-type="pmid">30206219</pub-id>
 </mixed-citation>
</ref>
